A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
Status: Terminated
Location: See all (58) locations...
Study Type: Observational
SUMMARY
The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Written informed consent obtained prior to the initiation of study procedures.
• Men ≥ 18 years of age.
• Histologically documented prostatic adenocarcinoma.
• History of Castration-Resistant Prostate Cancer.
Locations
United States
Alaska
Alaska Clinical Research Center, LLC
Anchorage
Arizona
Urological Associate of Southern Arizona
Tucson
California
Sequoia Urology Center
Atherton
Prostate Oncology Specialist, Inc.
Marina Del Rey
Sutter Medical Group
Sacramento
Genesis Research
San Diego
Urology Associates of San Luis Obispo
Templeton
Colorado
The Urology Center of Colorado
Denver
Advanced Urology, P.C
Parker
Washington, D.c.
Howard University Hospital
Washington
Florida
Urology Center of South Florida
Miami
Idaho
Idaho Urologic Institute
Meridian
Illinois
Comprehensive Urologic Care, SC
Lake Barrington
Uro Partners/ RMD Clinical Research
Melrose Park
Associated Urological Specialists, LLC
Palos Heights
Indiana
1st Urology, PSC
Jeffersonville
Northern Indiana Cancer Research Consortium
South Bend
Kansas
Kansas City Urology Care, PA
Overland Park
Cancer Center of Kansas
Wichita
Kentucky
Jewish Hospital
Louisville
Louisiana
Tulane University
New Orleans
Highland Clinic
Shreveport
Regional Urology, LLC
Shreveport
Maryland
Mid Atlantic Urology Associates
Greenbelt
Chesapeake Urology Research Associates
Towson
Michigan
Michigan Institute of Urology
Troy
Minnesota
Metro Urology
Plymouth
Metro Urology
Woodbury
Missouri
Saint Louis VAMS
Saint Louis
North Carolina
Durham Veterans Affairs Medical Center
Durham
Carolina Urology Partners
Gastonia
Nebraska
Southeast Nebraska Cancer Center
Lincoln
New Jersey
Urology Center Research Institute
Englewood
Delaware Valley Urology, LLC
Mount Laurel
New York
Montefiore Medical Center
Bronx
National Translational Research Group
East Setauket
Integrated Medical Professionals, PLLC
North Hills
Premier Medical Group of the Hudson Valley
Poughkeepsie
Associated Medical Professionals of NY, PLLC
Syracuse
Ohio
Central Ohio Urology Group
Gahanna
Clinical Research Solutions
Middleburg Heights
Oklahoma
Stepherson Cancer Center
Oklahoma City
Oregon
Portland Veterans Administration Medical Center
Portland
Oregon Urology Institute
Springfield
Pennsylvania
Urologic Consultants of SE PA
Bala-cynwyd
Urology Health Specialists, LLC
Bryn Mawr
Lancaster Urology
Lancaster
South Carolina
Carolina Urologic Research Center
Myrtle Beach
Tennessee
The Conrad Pearson Clinic
Germantown
Tennessee Urology Asociates
Knoxville
Urology Associates, P.C.
Nashville
Texas
Urology Clinics of North Texas
Dallas
Houston Metro Urology
Houston
UT Memorial Hermann Cancer Center
Houston
Oncology San Antonio Research LLC
San Antonio
Virginia
Virginia Urology
Richmond
Urology of Virginia, PLLC
Virginia Beach
Washington
Medical Oncology Associates
Spokane
Time Frame
Start Date: 2012-01
Completion Date: 2017-07
Participants
Target number of participants: 225
Authors
Stephen Freedland, Nathan Green, Michael Williams, Myron Murdock, Evan Goldfischer, Robert Waterhouse, William Aronson, Eric Margolis, Laurence Belkoff, Basir Tareen, Mark Scholz, Neal Shore, Chiledum Ahaghotu, Christopher Pieczonka, Bryan Mehlhaff, Arvind Chaudhry, Joseph Kuntze, Benjamin Gartrell, James Cochran, Ning Wu, Shaker Dakhil, James Bailen, Jeffrey Becker, Raoul S Concepcion, Guy Bernstein, Rafat Ansari, David Raminski, Ralph Henderson
Related Therapeutic Areas
Sponsors
Leads: Dendreon